Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sinopharm Group Co Ltd Class H (SHTDF)
OTHER OTC:SHTDF
RESEARCH TOOLSreports
Sinopharm Group Co (SHTDF) Stock Price & Analysis
54 Followers
SHTDF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.18 - $3.65
Previous Close$2.54
Volume536.00
Average Volume (3M)823.00
Market Cap
$7.85B
Enterprise Value$21.57B
Total Cash (Recent Filing)¥32.15B
Total Debt (Recent Filing)¥91.90B
Price to Earnings (P/E)6.1
Beta0.28
Next Earnings
Apr 25, 2024EPS EstimateN/A
Next Dividend Ex-Date
Jun 17, 2024Dividend Yield4.57%
Share Statistics
EPS (TTM)0.41
Shares OutstandingN/A
10 Day Avg. Volume262
30 Day Avg. Volume823
Standard Deviation0.11
R-Squared0.09
Alpha-0.00520
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.59Price Target Upside41.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Financial Health ImprovementAccounts receivable days are expected to improve, positively influencing the share price.
Government Policy ImpactGovernment initiatives requiring SOEs to boost their market cap have resulted in a share price increase for Sinopharm.
Market Share ExpansionSinopharm is expected to expand its market share due to industry consolidation and government policies.
Bears Say
Earnings ForecastAnalysts have lowered earnings expectations for Sinopharm, reflecting concerns over government pricing pressure and the impact of an anti-corruption campaign.
Financial PerformanceSinopharm's gross margin is anticipated to fall short of the target, influenced by ongoing pricing pressures.
Regulatory InfluencePrice cuts by the government may lead to a decline in profits for Sinopharm.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
15.70% Mutual Funds
9.01% Other Institutional Investors
75.29% Public Companies and
Individual Investors
SHTDF FAQ
What was Sinopharm Group Co Ltd Class H’s price range in the past 12 months?
Sinopharm Group Co Ltd Class H lowest stock price was $2.18 and its highest was $3.65 in the past 12 months.
What is Sinopharm Group Co Ltd Class H’s market cap?
Currently, no data Available
When is Sinopharm Group Co Ltd Class H’s upcoming earnings report date?
Sinopharm Group Co Ltd Class H’s upcoming earnings report date is Apr 25, 2024 which is today.
How were Sinopharm Group Co Ltd Class H’s earnings last quarter?
Sinopharm Group Co Ltd Class H released its earnings results on Mar 25, 2024. The company reported $0.131 earnings per share for the quarter, missing the consensus estimate of $0.209 by -$0.078.
Is Sinopharm Group Co Ltd Class H overvalued?
According to Wall Street analysts Sinopharm Group Co Ltd Class H’s price is currently Undervalued.
Does Sinopharm Group Co Ltd Class H pay dividends?
Sinopharm Group Co Ltd Class H pays a Annually dividend of $0.12 which represents an annual dividend yield of 4.57%. See more information on Sinopharm Group Co Ltd Class H dividends here
What is Sinopharm Group Co Ltd Class H’s EPS estimate?
Sinopharm Group Co Ltd Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sinopharm Group Co Ltd Class H have?
Sinopharm Group Co Ltd Class H has 1,341,810,800 shares outstanding.
What happened to Sinopharm Group Co Ltd Class H’s price movement after its last earnings report?
Sinopharm Group Co Ltd Class H reported an EPS of $0.131 in its last earnings report, missing expectations of $0.209. Following the earnings report the stock price went down -5.303%.
Which hedge fund is a major shareholder of Sinopharm Group Co Ltd Class H?
Currently, no hedge funds are holding shares in SHTDF
---
Sinopharm Group Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.87%
12-Months-Change
Fundamentals
Return on Equity
12.57%
Trailing 12-Months
Asset Growth
3.02%
Trailing 12-Months
Company Description
Sinopharm Group Co Ltd Class H
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment is distributes medical devices, financial leasing ,production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
---
SHTDF Stock 12 Months Forecast
Average Price Target
$3.59
▲(41.34% Upside)
Technical Analysis
Best Analysts Covering SHTDF
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-0.30%
reiterated a buy rating last month
Copying Laurence Tam's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -0.30% per trade.
---